MedPath

Versameb AG

Versameb AG logo
🇨🇭Switzerland
Ownership
Holding
Established
2017-07-31
Employees
11
Market Cap
-
Website
http://www.versameb.com

A Phase 2a Study To Evaluate VMB-100 In Females With Stress Urinary Incontinence

Phase 2
Not yet recruiting
Conditions
Stress Urinary Incontinence
Interventions
First Posted Date
2024-02-07
Last Posted Date
2025-04-01
Lead Sponsor
Versameb AG
Target Recruit Count
30
Registration Number
NCT06247241
© Copyright 2025. All Rights Reserved by MedPath